|
US8481043B2
(en)
*
|
2001-06-22 |
2013-07-09 |
Cpex Pharmaceuticals, Inc. |
Nasal immunization
|
|
US20050191321A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
US9078892B2
(en)
*
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
JP5276982B2
(ja)
|
2005-08-26 |
2013-08-28 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
オキシトシンの投与による頭痛の処置のための方法
|
|
US8883507B2
(en)
|
2005-10-18 |
2014-11-11 |
The Regents Of The University Of Colorado |
Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
|
|
SI3045182T1
(en)
|
2005-11-14 |
2018-08-31 |
Teva Pharmaceuticals International Gmbh |
An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
|
|
US20080261893A1
(en)
*
|
2006-02-24 |
2008-10-23 |
Denise Barbut |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
WO2007120485A2
(en)
*
|
2006-03-30 |
2007-10-25 |
Cinergen, Llc |
Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
|
|
GB2438834A
(en)
|
2006-06-08 |
2007-12-12 |
Optinose As |
Intranasal protein administration
|
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
|
WO2008112807A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Sarentis Therapeutics, Inc. |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
CA2680613A1
(en)
*
|
2007-03-13 |
2008-09-18 |
National Jewish Medical And Research Center |
Methods for generation of antibodies
|
|
EP2152240A4
(en)
*
|
2007-06-08 |
2012-05-09 |
Healthpartners Res Foundation |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
|
|
US9707274B2
(en)
|
2007-06-08 |
2017-07-18 |
Healthpartners Research & Education |
Methods for preventing and treating post-traumatic stress disorder (PTSD)
|
|
US20100221200A1
(en)
*
|
2007-07-17 |
2010-09-02 |
The Ohio State University Research Foundation |
Compositions and methods for skin care
|
|
AU2008303928A1
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection
|
|
AU2008306264A1
(en)
*
|
2007-09-11 |
2009-04-09 |
Mondobiotech Laboratories Ag |
Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
|
|
KR20100061481A
(ko)
*
|
2007-09-11 |
2010-06-07 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 미니가스트린
|
|
KR20100059863A
(ko)
*
|
2007-09-11 |
2010-06-04 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 펩티드 티모신 베타 4 단독 또는 세크로핀 a와의 배합물의 용도
|
|
WO2009033489A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Glostrup Hospital |
Selective pacl inhibitors for use in the treatment of migraine and headaches
|
|
KR101304150B1
(ko)
|
2008-03-04 |
2013-09-05 |
라브리스 바이올로직스 인코포레이티드 |
만성 통증의 치료 방법
|
|
US20110117106A1
(en)
*
|
2008-03-06 |
2011-05-19 |
Alice Prince |
Uses of calpain inhibitors to inhibit inflammation
|
|
US20090246273A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Ketorolac Sublingual Spray for the Treatment of Pain
|
|
SG10201803982TA
(en)
|
2008-05-16 |
2018-07-30 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
|
FR2932483A1
(fr)
*
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
|
DK2313496T3
(en)
*
|
2008-07-21 |
2014-12-15 |
Taiga Biotechnologies Inc |
Anukleære differentiated cells, and method for preparation thereof
|
|
US8784825B2
(en)
|
2008-08-28 |
2014-07-22 |
Taiga Biotechnologies, Inc. |
Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
|
|
WO2010029555A1
(en)
*
|
2008-09-12 |
2010-03-18 |
Slender Medical, Ltd. |
Virtual ultrasonic scissors
|
|
WO2010029441A2
(en)
*
|
2008-09-15 |
2010-03-18 |
Optinose As |
Nasal delivery
|
|
CA2739936C
(en)
*
|
2008-10-17 |
2017-12-12 |
Pharmacofore, Inc. |
Pharmaceutical compositions with attenuated release of phenolic opioids
|
|
US8575309B2
(en)
|
2008-12-08 |
2013-11-05 |
Biousian Biosystems, Inc. |
Delta-opioid receptor selective analgesics
|
|
EP3620154A1
(en)
*
|
2009-02-06 |
2020-03-11 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
US20100291160A1
(en)
*
|
2009-05-13 |
2010-11-18 |
Carver David R |
Pharmaceutical system for trans-membrane delivery
|
|
WO2011001676A1
(ja)
*
|
2009-07-02 |
2011-01-06 |
国立大学法人山口大学 |
表面麻酔剤
|
|
DK2459183T3
(en)
*
|
2009-07-27 |
2016-01-18 |
Nocicepta Llc |
Methods for the treatment of pain
|
|
FR2948809B1
(fr)
*
|
2009-07-31 |
2012-08-17 |
St Microelectronics Rousset |
Amplificateur de lecture faible puissance auto-minute
|
|
BR112012004464B8
(pt)
|
2009-08-28 |
2021-05-25 |
Labrys Biologics Inc |
uso de um anticorpo antagonista anti-cgrp para preparar uma composição farmacêutica para tratar e/ou prevenir dor visceral e/ou um ou mais sintomas de dor visceral, em que a dor visceral está associada á cistite intersticial (ic), e dita composição farmacêutica
|
|
JP2013503862A
(ja)
|
2009-09-08 |
2013-02-04 |
シグネーチャー セラピューティクス,インク. |
酵素切断可能なケトン修飾オピオイドプロドラッグとその任意選択のインヒビターとを含んでなる組成物
|
|
US8622993B2
(en)
*
|
2009-12-18 |
2014-01-07 |
Healthpartners Research Foundation |
Device and method for delivering therapeutic substances to the maxillary sinus of a patient
|
|
JP6200648B2
(ja)
*
|
2009-12-18 |
2017-09-20 |
アケリオス セラピューティクス,インコーポレーテッド |
三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
|
|
US20110184322A1
(en)
*
|
2010-01-22 |
2011-07-28 |
Slender Medical Ltd. |
Method and device for treatment of keloids and hypertrophic scars using focused ultrasound
|
|
CN104744215B
(zh)
|
2010-03-03 |
2019-03-15 |
尼昂克技术公司 |
包含单萜的药物组合物
|
|
US9238020B2
(en)
|
2010-04-21 |
2016-01-19 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
|
|
WO2011133179A1
(en)
*
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc |
Compositions comprising enzyme-cleavable hydromorphone prodrug
|
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
US20130059914A1
(en)
|
2010-04-21 |
2013-03-07 |
Signature Therapeutics, Inc. |
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
|
|
US8956346B2
(en)
|
2010-05-14 |
2015-02-17 |
Rainbow Medical, Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
US8617150B2
(en)
|
2010-05-14 |
2013-12-31 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment
|
|
US9242122B2
(en)
|
2010-05-14 |
2016-01-26 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
CN102905720A
(zh)
|
2010-05-18 |
2013-01-30 |
日内瓦大学 |
催产素样分子的新用途及相关的方法
|
|
US20120009261A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Grünenthal GmbH |
Novel gastro-retentive dosage forms
|
|
US9499461B2
(en)
|
2010-08-27 |
2016-11-22 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising POH derivatives
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
GB201015371D0
(en)
*
|
2010-09-14 |
2010-10-27 |
Optinose As |
Nasal delivery
|
|
US8647661B1
(en)
*
|
2010-11-05 |
2014-02-11 |
Florida A&M University |
Surface modified multilayered nanostructures for dermal delivery
|
|
ES3056006T3
(en)
|
2010-12-17 |
2026-02-17 |
Univ Southern California |
Methods and devices for using isoperillyl alcohol
|
|
AU2012205733B2
(en)
|
2011-01-11 |
2015-10-08 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
|
WO2012096886A1
(en)
|
2011-01-11 |
2012-07-19 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
|
US20120183580A1
(en)
*
|
2011-01-13 |
2012-07-19 |
Theralpha |
Analgesic Composition for Transbuccal Administration
|
|
US10687975B2
(en)
*
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US12533312B2
(en)
|
2011-02-04 |
2026-01-27 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
EP2683394B1
(en)
|
2011-03-09 |
2021-01-06 |
Signature Therapeutics, Inc. |
Active agent prodrugs with heterocyclic linkers
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
US9949923B2
(en)
|
2011-03-15 |
2018-04-24 |
Optinose As |
Nasal delivery
|
|
PT2694050T
(pt)
*
|
2011-04-05 |
2019-11-22 |
Gruenenthal Gmbh |
Tapentadol para uso no tratamento da dor associada à neuralgia trigeminal
|
|
SI2694049T1
(sl)
|
2011-04-05 |
2019-01-31 |
Gruenenthal Gmbh |
Tapentadol za preprečevanje razvoja kronične bolečine
|
|
PT2701693T
(pt)
|
2011-04-29 |
2017-11-16 |
Gruenenthal Gmbh |
Tapentadol para prevenção e tratamento de depressão e ansiedade
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
US8987199B2
(en)
|
2011-06-15 |
2015-03-24 |
Nerve Access, Inc. |
Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
|
|
US11213501B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US10813897B2
(en)
|
2011-12-27 |
2020-10-27 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9468599B2
(en)
*
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9962391B2
(en)
|
2011-12-27 |
2018-05-08 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US11213500B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
AU2013207346A1
(en)
*
|
2012-01-05 |
2014-06-05 |
Beech Tree Labs, Inc. |
Method of treating pain by administration of Nerve Growth Factor
|
|
US9707414B2
(en)
|
2012-02-14 |
2017-07-18 |
Rainbow Medical Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
AU2013219799C1
(en)
|
2012-02-15 |
2017-12-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of treating and preventing diseases and disorders of the central nervous system
|
|
JP6285930B2
(ja)
|
2012-07-20 |
2018-02-28 |
タイガ バイオテクノロジーズ,インク. |
造血コンパートメントの再構築及び自家再構築の増進
|
|
ES2442242B1
(es)
*
|
2012-08-09 |
2014-11-25 |
Biotechnology Institute, I Mas D, S.L. |
Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
|
|
WO2014068577A2
(en)
|
2012-11-05 |
2014-05-08 |
Rainbow Medical Ltd. |
Controlled tissue ablation
|
|
US9770593B2
(en)
|
2012-11-05 |
2017-09-26 |
Pythagoras Medical Ltd. |
Patient selection using a transluminally-applied electric current
|
|
CN104813167B
(zh)
*
|
2012-11-28 |
2019-04-09 |
尼克塔治疗公司 |
用于评估和预测用一种长效拓扑异构酶i抑制剂进行乳腺癌治疗的疗效的方法
|
|
US9050330B2
(en)
*
|
2012-12-06 |
2015-06-09 |
Jose C. Ramon-de-Jesus |
Method, composition and kit for treating frequent headaches
|
|
US10639439B2
(en)
|
2013-01-30 |
2020-05-05 |
Midwest Pharmaceuticals, Llc |
Smokeless THC and administration method thereof
|
|
US20140294923A1
(en)
*
|
2013-02-20 |
2014-10-02 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
KR102215405B1
(ko)
|
2013-03-15 |
2021-02-10 |
암젠 인크 |
인간 pac1 항체
|
|
JP2016523835A
(ja)
|
2013-05-15 |
2016-08-12 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入
|
|
US20150086616A1
(en)
*
|
2013-09-20 |
2015-03-26 |
Steven Lehrer |
Method for the prevention and treatment of alzheimer's disease
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
MX378344B
(es)
|
2014-03-21 |
2025-03-10 |
Teva Pharmaceuticals Int Gmbh |
Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
|
|
US10556945B2
(en)
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
WO2015170281A1
(en)
|
2014-05-07 |
2015-11-12 |
Rainbow Medical Ltd |
Controlled tissue ablation techniques
|
|
CA2952622A1
(en)
*
|
2014-06-16 |
2015-12-23 |
Loewi LLC |
Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
|
|
UY36302A
(es)
|
2014-09-15 |
2016-04-29 |
Amgen Inc |
Proteína de unión a antígenos, bi-específicos del receptor anti-cgrp/receptor pac1 y usos de las mismas
|
|
RU2719416C2
(ru)
|
2014-10-01 |
2020-04-17 |
Окситон Байосайенс Б.В. |
Перорально распадающаяся твердая фармацевтическая единица дозирования, содержащая контролирующее родовую деятельность вещество
|
|
CN106999436B
(zh)
|
2014-10-01 |
2021-07-02 |
奥克希托恩生物科学公司 |
含有分娩控制物质的口服崩解固体药物剂量单元
|
|
CN107106542B
(zh)
|
2014-10-20 |
2020-05-08 |
奥伊斯特普安生物制药公司 |
治疗眼部病状的方法
|
|
WO2016065075A1
(en)
|
2014-10-21 |
2016-04-28 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
|
US10388407B2
(en)
|
2014-10-21 |
2019-08-20 |
uBiome, Inc. |
Method and system for characterizing a headache-related condition
|
|
ES2949052T3
(es)
|
2014-11-19 |
2023-09-25 |
Optinose Inc |
Administración intranasal
|
|
CN107614061A
(zh)
*
|
2014-12-01 |
2018-01-19 |
阿科莱尔斯疗法公司 |
用于治疗与疼痛有关的偏头痛和病症方法和组合物
|
|
PL3242676T3
(pl)
|
2015-01-07 |
2024-07-15 |
Tonix Pharma Limited |
Preparaty oksytocyny zawierające magnez i sposoby ich stosowania
|
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9375478B1
(en)
|
2015-01-30 |
2016-06-28 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
WO2016130800A2
(en)
|
2015-02-12 |
2016-08-18 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
|
WO2016140063A1
(ja)
*
|
2015-03-04 |
2016-09-09 |
栄研化学株式会社 |
オキシトシンの高感度測定法
|
|
CA2983030A1
(en)
|
2015-04-16 |
2016-10-20 |
Alder Biopharmaceuticals, Inc. |
Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
|
|
US10383685B2
(en)
|
2015-05-07 |
2019-08-20 |
Pythagoras Medical Ltd. |
Techniques for use with nerve tissue
|
|
US11207461B2
(en)
|
2015-07-30 |
2021-12-28 |
Anoop U. R |
Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier
|
|
US11213480B1
(en)
|
2015-08-06 |
2022-01-04 |
Hikma Pharmaceuticals International Limited |
Phenylephrine hydrochloride ready-to-use solution
|
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
|
WO2017059459A1
(en)
|
2015-10-01 |
2017-04-06 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
|
US10822408B2
(en)
|
2015-12-15 |
2020-11-03 |
Amgen Inc. |
PACAP antibodies and uses thereof
|
|
HRP20250215T1
(hr)
|
2016-04-12 |
2025-06-20 |
Tonix Pharma Limited |
Formulacije oksitocina koje sadrže magnezij i postupci upotrebe
|
|
US11253612B2
(en)
|
2016-04-15 |
2022-02-22 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type II
|
|
SG10202109691UA
(en)
|
2016-04-15 |
2021-10-28 |
Alder Biopharmaceuticals Inc |
Anti-pacap antibodies and uses thereof
|
|
US11678932B2
(en)
|
2016-05-18 |
2023-06-20 |
Symap Medical (Suzhou) Limited |
Electrode catheter with incremental advancement
|
|
SMT202600087T1
(it)
|
2016-09-23 |
2026-03-09 |
Teva Pharmaceuticals Int Gmbh |
Trattamento dell’emicrania refrattaria
|
|
WO2018094376A1
(en)
*
|
2016-11-21 |
2018-05-24 |
uBiome, Inc. |
Method and system for characterizing a headache-related condition
|
|
CN110267538B
(zh)
|
2016-11-30 |
2022-04-19 |
尼昂克技术公司 |
紫苏醇-3-溴丙酮酸缀合物和治疗癌症的方法
|
|
US10583156B2
(en)
|
2016-12-02 |
2020-03-10 |
Taiga Biotechnologies, Inc. |
Nanoparticle formulations
|
|
US10456419B2
(en)
|
2017-02-27 |
2019-10-29 |
Payman Sadeghi |
Method for treating migraine headaches
|
|
US10932711B2
(en)
|
2017-02-27 |
2021-03-02 |
Payman Sadeghi |
Method and system for neurohydrodissection
|
|
CA3056239C
(en)
|
2017-03-17 |
2023-09-12 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
|
EP3684938A1
(en)
|
2017-09-22 |
2020-07-29 |
The Trustees of the University of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type ii
|
|
JP7339262B2
(ja)
*
|
2018-01-12 |
2023-09-05 |
アムジェン インコーポレイテッド |
Pac1抗体及びその使用
|
|
JP7325425B2
(ja)
|
2018-02-08 |
2023-08-14 |
ネオンク テクノロジーズ インク. |
血液脳関門を透過性にする方法
|
|
US20210346385A1
(en)
*
|
2018-09-21 |
2021-11-11 |
MSB Holdings, Inc |
Taste-masked dosage forms
|
|
US11135379B2
(en)
|
2019-02-15 |
2021-10-05 |
Bn Intellectual Properties, Inc. |
Method of delivering pharmaceutical products
|
|
WO2020182322A1
(en)
|
2019-03-14 |
2020-09-17 |
Om Pharma Sa |
Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders
|
|
EP3952909A4
(en)
|
2019-04-08 |
2023-06-07 |
Taiga Biotechnologies, Inc. |
COMPOSITIONS AND METHODS FOR CRYOPRESERVING IMMUNE CELLS
|
|
SG11202112529WA
(en)
|
2019-05-14 |
2021-12-30 |
Taiga Biotechnologies Inc |
Compositions and methods for treating t cell exhaustion
|
|
WO2021016190A1
(en)
*
|
2019-07-19 |
2021-01-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for modulating drug-use disorders
|
|
US11364225B2
(en)
*
|
2019-08-21 |
2022-06-21 |
Bn Intellectual Properties, Inc. |
Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
|
|
US11241477B2
(en)
*
|
2019-08-29 |
2022-02-08 |
New York University |
Oxytocin compositions for treatment of tinnitus
|
|
US20240100120A1
(en)
*
|
2019-10-11 |
2024-03-28 |
Board Of Regents, The University Of Taxas System |
Compositions and methods for preventing, reducing and reversing opioid-induced respiratory depression
|
|
AU2021211012A1
(en)
|
2020-01-24 |
2022-08-25 |
Aim Immunotech Inc. |
Methods, compositions, and vaccines for treating a virus infection
|
|
KR20240127867A
(ko)
*
|
2020-08-10 |
2024-08-23 |
지로파, 인코포레이티드 |
국소 전달을 위한 조성물 및 방법
|
|
KR20230174213A
(ko)
|
2021-03-09 |
2023-12-27 |
엔사이스 바이오사이언시즈 인크. |
나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
|
|
CN117715632A
(zh)
|
2021-03-09 |
2024-03-15 |
恩赛斯生物科学股份有限公司 |
包含酶可裂解的前药和萘莫司他的组合物及其使用方法
|
|
MX2024003466A
(es)
|
2021-09-29 |
2024-06-04 |
Ensysce Biosciences Inc |
Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.
|
|
WO2023146579A1
(en)
*
|
2022-01-27 |
2023-08-03 |
Belnap Pharmaceuticals, Llc |
Methods of treatment using oxytocin
|
|
WO2024102741A2
(en)
*
|
2022-11-07 |
2024-05-16 |
AEON Biopharma, Inc. |
Compositions for use in treating headache disorders
|
|
WO2025064708A1
(en)
*
|
2023-09-22 |
2025-03-27 |
The George Washington University |
Compositions comprising oxytocin and methods of treating opioid overdose
|
|
WO2025199179A2
(en)
|
2024-03-18 |
2025-09-25 |
Tonix Pharmaceuticals Holding Corp. |
Oxytocin peptide analogs
|